Related references
Note: Only part of the references are listed.A Smurf1 tale: function and regulation of an ubiquitin ligase in multiple cellular networks
Yu Cao et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Discovery of Coumarin-Dihydropyridine Hybrids as Bone Anabolic Agents
Koneni V. Sashidhara et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Osteogenic efficacy enhancement of kaempferol through an engineered layer-by-layer matrix: a study in ovariectomized rats
Girish K. Gupta et al.
NANOMEDICINE (2013)
De Novo Assembly, Functional Annotation and Comparative Analysis of Withania somnifera Leaf and Root Transcriptomes to Identify Putative Genes Involved in the Withanolides Biosynthesis
Parul Gupta et al.
PLOS ONE (2013)
E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis
N. Severe et al.
CELL DEATH & DISEASE (2013)
Constituents of Dalbergia sissoo Roxb. leaves with osteogenic activity
Preety Dixit et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
In vivo efficacy studies of layer-by-layer nano-matrix bearing kaempferol for the conditions of osteoporosis: A study in ovariectomized rat model
Avinash Kumar et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2012)
Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival
Katherine J. Motyl et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
EGb 761 promotes osteoblastogenesis, lowers bone marrow adipogenesis and atherosclerotic plaque formation
Jyoti Gautam et al.
PHYTOMEDICINE (2012)
Lactacystin, a proteasome inhibitor, enhances BMP-induced osteoblastic differentiation by increasing active Smads
Yuki Ito et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Impaired bone healing pattern in mice with ovariectomy-induced osteoporosis: A drill-hole defect model
Yi-Xin He et al.
BONE (2011)
Increased Bone Mass in Mice after Single Injection of Anti-receptor Activator of Nuclear Factor-κB Ligand-neutralizing Antibody EVIDENCE FOR BONE ANABOLIC EFFECT OF PARATHYROID HORMONE IN MICE WITH FEW OSTEOCLASTS
Yuriko Furuya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
A Novel Quercetin Analogue From a Medicinal Plant Promotes Peak Bone Mass Achievement and Bone Healing After Injury and Exerts an Anabolic Effect on Osteoporotic Bone: The Role of Aryl Hydrocarbon Receptor as a Mediator of Osteogenic Action
Kunal Sharan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
A naturally occurring rare analog of quercetin promotes peak bone mass achievement and exerts anabolic effect on osteoporotic bone
J. A. Siddiqui et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Effects of obesity on bone metabolism
Jay J. Cao
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2011)
Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes
Abhinav Grover et al.
BMC GENOMICS (2010)
Deficiency of vitamin A delays bone healing process in association with reduced BMP2 expression after drill-hole injury in mice
Kazuhiro Tanaka et al.
BONE (2010)
Anabolics in Osteoporosis: The Emerging Therapeutic Tool
R. Trivedi et al.
CURRENT MOLECULAR MEDICINE (2010)
Investigational anabolic therapies for osteoporosis
Ritu Trivedi et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Proteasome inhibition with bortezomib suppresses growth and induces apoptosis in osteosarcoma
Yuriy Shapovalov et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Cooperative Role of NF-κB and Poly(ADP-ribose) Polymerase 1 (PARP-1) in the TNF-induced Inhibition of PHEX Expression in Osteoblasts
Pawel M. Majewski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Medicarpin inhibits osteoclastogenesis and has nonestrogenic bone conserving effect in ovariectomized mice
Abdul M. Tyagi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Identification of kaempferol-regulated proteins in rat calvarial osteoblasts during mineralization by proteomics
Avinash Kumar et al.
PROTEOMICS (2010)
Signaling to NF-κB: Regulation by Ubiquitination
Ingrid E. Wertz et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Inhibition of NFκB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammation
Rangan Maitra et al.
JOURNAL OF INFLAMMATION-LONDON (2009)
Effects of Egb 761 on bone mineral density, bone microstructure, and osteoblast function: Possible roles of quercetin and kaempferol
Ritu Trivedi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Heparin inhibits osteoclastic differentiation and function
Wataru Ariyoshi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Akt1 in Osteoblasts and Osteoclasts Controls Bone Remodeling
Naohiro Kawamura et al.
PLOS ONE (2007)
The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients
Nicola Giuliani et al.
BLOOD (2007)
The tumor proteasome is a primary target for the natural anticancer compound withaferin a isolated from Indian Winter Cherry
Huanjie Yang et al.
MOLECULAR PHARMACOLOGY (2007)
T cells and post menopausal osteoporosis in murine models
Roberto Pacifici
ARTHRITIS RESEARCH & THERAPY (2007)
Bone morphogenetic protein-2 stimulates Runx2 acetylation
Eun-Joo Jeon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Estrogen deficiency and bone loss: an inflammatory tale
MN Weitzmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts
H Kaneki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mechanisms of disease: is osteoporosis the obesity of bone?
CJ Rosen et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Bisphosphonate (YM529) delays the repair of cortical bone defect after drill-hole injury by reducing terminal differentiation of osteoblasts in the mouse femur
M Nagashima et al.
BONE (2005)
Expression of bone morphogenetic proteins, receptors, and tissue inhibitors in human fetal, adult, and osteoarthritic articular cartilage
AL Chen et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2004)
Bone loss and bone size after menopause
HG Ahlborg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro
IR Garrett et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Bone morphogenetic proteins, their antagonists, and the skeleton
E Canalis et al.
ENDOCRINE REVIEWS (2003)
The effects of Lovastatin on proteasome activities in highly purified rabbit 20 S proteasome preparations and mouse MC3T3-E1 osteoblastic cells
SS Murray et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2002)
Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFκB
D Cappellen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Regulatory mechanisms of osteoblast and osteoclast differentiation
T Katagiri et al.
ORAL DISEASES (2002)
Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2αA) is inhibited by tumor necrosis factor-α
L Gilbert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera Dunal. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum
H Matsuda et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2001)
Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase
Y Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women
FA Tremollieres et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12
KS Lee et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
